Background: Guidelines advocate >7 d of broad-spectrum antibiotics for unexplained fever (UF) during neutropaenia. However, effective antimicrobial prophylaxis reduces the incidence of gram-negative infections, which may allow shorter treatment. This study evaluates the safety of discontinuing empirical broad-spectrum antibiotics if no microbial source is documented after an initial work-up of 72 h. Methods: Prospective observational study at a tertiary-care haematology-unit in patients suffering from haematologic malignancies and treatment-induced prolonged neutropaenia of >= 10 d. oral fluoroquinolone and fluconazole prophylaxis was given from day 1. Fever was empirically treated with imipenem which was discontinued after 72 h if, followi...
Infectious complications are an important cause of morbidity and mortality in patients with hematolo...
Background: Induction chemotherapy for acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS...
The prophylactic use of fluoroquinolones in patients with cancer and neutropenia is controversial an...
SummaryBackgroundThe routine use of fluoroquinolone prophylaxis in patients with neutropenia and hem...
Background: Recent research in febrile neutropaenia (FN) has focused on reducing the intensity of tr...
Abstract: Febrile neutropenia causes significant morbidity and mortality in patients receiving antin...
(See the editorial commentary by Zinner on pages 1094–5) Background. Fluoroquinolone prophylaxis dur...
Objectives Review the consequences of febrile episodes in neutropenic patients Discuss the current g...
OBJECTIVES: Fluoroquinolone (FQ) prophylaxis was recommended in 2005 by European Conference on Infec...
Fluoroquinolone (FQ) prophylaxis was recommended in 2005 by European Conference on Infections in Leu...
The benefits of oral prophylaxis for neutropenia have remained controversial up to now. We evaluated...
During a 2-year period, all children with cancer, neutropenia, and fever who were admitted to Hospit...
PURPOSE: Prompt antibiotic therapy is standard of care for patients with fever and neutropenia (FN) ...
Background: Febrile neutropenia (FN) is an oncologic emergency which should be treated immediately w...
Summary: Objectives: The aim of this study was to describe the antimicrobial prescription patterns ...
Infectious complications are an important cause of morbidity and mortality in patients with hematolo...
Background: Induction chemotherapy for acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS...
The prophylactic use of fluoroquinolones in patients with cancer and neutropenia is controversial an...
SummaryBackgroundThe routine use of fluoroquinolone prophylaxis in patients with neutropenia and hem...
Background: Recent research in febrile neutropaenia (FN) has focused on reducing the intensity of tr...
Abstract: Febrile neutropenia causes significant morbidity and mortality in patients receiving antin...
(See the editorial commentary by Zinner on pages 1094–5) Background. Fluoroquinolone prophylaxis dur...
Objectives Review the consequences of febrile episodes in neutropenic patients Discuss the current g...
OBJECTIVES: Fluoroquinolone (FQ) prophylaxis was recommended in 2005 by European Conference on Infec...
Fluoroquinolone (FQ) prophylaxis was recommended in 2005 by European Conference on Infections in Leu...
The benefits of oral prophylaxis for neutropenia have remained controversial up to now. We evaluated...
During a 2-year period, all children with cancer, neutropenia, and fever who were admitted to Hospit...
PURPOSE: Prompt antibiotic therapy is standard of care for patients with fever and neutropenia (FN) ...
Background: Febrile neutropenia (FN) is an oncologic emergency which should be treated immediately w...
Summary: Objectives: The aim of this study was to describe the antimicrobial prescription patterns ...
Infectious complications are an important cause of morbidity and mortality in patients with hematolo...
Background: Induction chemotherapy for acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS...
The prophylactic use of fluoroquinolones in patients with cancer and neutropenia is controversial an...